{"id":"https://openalex.org/W588762688","doi":null,"title":"Efficacy of ISTH0036, a Potent and Selective Antisense Oligonucleotide Targeting Transforming Growth Factor beta 2 (TGF-\u03b22) Isoform, in Different Ocular Disease Preclinical Models","display_name":"Efficacy of ISTH0036, a Potent and Selective Antisense Oligonucleotide Targeting Transforming Growth Factor beta 2 (TGF-\u03b22) Isoform, in Different Ocular Disease Preclinical Models","publication_year":2015,"publication_date":"2015-06-11","ids":{"openalex":"https://openalex.org/W588762688","mag":"588762688"},"language":"en","primary_location":{"id":"mag:588762688","doi":null,"is_oa":false,"landing_page_url":"https://iovs.arvojournals.org/Article.aspx?articleid=2330973","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103172709","display_name":"Michel Janicot","orcid":"https://orcid.org/0000-0002-4669-9641","observed_orcids":["https://orcid.org/0000-0002-4669-9641"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michel Janicot","raw_affiliation_strings":["JMi ONConsulting, Brussels, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-4669-9641","affiliations":[{"raw_affiliation_string":"JMi ONConsulting, Brussels, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085497578","display_name":"Kathy Hasenbach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165898","display_name":"Isarna Therapeutics (Germany)","ror":"https://ror.org/05xp1nk14","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210165898"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kathy Hasenbach","raw_affiliation_strings":["Preclinical RnD, Isarna Therapeutics, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical RnD, Isarna Therapeutics, Munich, Germany","institution_ids":["https://openalex.org/I4210165898"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000373690","display_name":"Tine Van Bergen","orcid":"https://orcid.org/0000-0002-8761-9214","observed_orcids":["https://orcid.org/0000-0002-8761-9214"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Tine Van Bergen","raw_affiliation_strings":["Laboratory of Ophthalmology, KUL, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-8761-9214","affiliations":[{"raw_affiliation_string":"Laboratory of Ophthalmology, KUL, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088679649","display_name":"Lieve Moons","orcid":"https://orcid.org/0000-0003-0186-1411","observed_orcids":["https://orcid.org/0000-0003-0186-1411"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Lieve Moons","raw_affiliation_strings":["Department of Biology, Zoological Institute, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0003-0186-1411","affiliations":[{"raw_affiliation_string":"Department of Biology, Zoological Institute, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043917421","display_name":"Ingeborg Stalmans","orcid":"https://orcid.org/0000-0001-7507-4512","observed_orcids":["https://orcid.org/0000-0001-7507-4512"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Ingeborg Stalmans","raw_affiliation_strings":["Laboratory of Ophthalmology, KUL, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0001-7507-4512","affiliations":[{"raw_affiliation_string":"Laboratory of Ophthalmology, KUL, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063492070","display_name":"Katja Wosikowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165898","display_name":"Isarna Therapeutics (Germany)","ror":"https://ror.org/05xp1nk14","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210165898"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Katja Wosikowski","raw_affiliation_strings":["Preclinical RnD, Isarna Therapeutics, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical RnD, Isarna Therapeutics, Munich, Germany","institution_ids":["https://openalex.org/I4210165898"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1850,"currency":"USD","value_usd":1850},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01192526,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"56","issue":"7","first_page":"1278","last_page":"1278"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.2418999969959259,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.2418999969959259,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.20630000531673431,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.12409999966621399,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9679999947547913},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta2","display_name":"transforming growth factor-beta2","score":0.8949999809265137},{"id":"https://openalex.org/keywords/eye-diseases","display_name":"eye diseases","score":0.8190000057220459},{"id":"https://openalex.org/keywords/preclinical-models","display_name":"preclinical models","score":0.925000011920929},{"id":"https://openalex.org/keywords/gene-silencing","display_name":"gene silencing","score":0.5580000281333923},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C53345823","wikidata":"https://www.wikidata.org/wiki/Q5531554","display_name":"Gene isoform","level":3,"score":0.7407035231590271},{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.7002081871032715},{"id":"https://openalex.org/C2778229498","wikidata":"https://www.wikidata.org/wiki/Q24785672","display_name":"Transforming growth factor beta","level":3,"score":0.6320122480392456},{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.5461344718933105},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.502314567565918},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.4492895305156708},{"id":"https://openalex.org/C111001777","wikidata":"https://www.wikidata.org/wiki/Q3562192","display_name":"TGF beta signaling pathway","level":3,"score":0.4267592132091522},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4232177734375},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3537399172782898},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3520636558532715},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33378100395202637},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3141477108001709},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31171101331710815},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21179533004760742},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12915197014808655},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11368224024772644},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.08644849061965942},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:588762688","doi":null,"is_oa":false,"landing_page_url":"https://iovs.arvojournals.org/Article.aspx?articleid=2330973","pdf_url":null,"source":{"id":"https://openalex.org/S76304953","display_name":"Investigative Ophthalmology & Visual Science","issn_l":"0146-0404","issn":["0146-0404","1552-5783"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310321950","host_organization_name":"Cadmus Press","host_organization_lineage":["https://openalex.org/P4310321950"],"host_organization_lineage_names":["Cadmus Press"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Investigative Ophthalmology & Visual Science","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2927354514","https://openalex.org/W796560098","https://openalex.org/W3185389468","https://openalex.org/W2588502396","https://openalex.org/W2593157071","https://openalex.org/W2596350593","https://openalex.org/W1742447236","https://openalex.org/W2741895730","https://openalex.org/W753702718","https://openalex.org/W3178692639"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2025-10-10T17:16:08.811792","created_date":"2016-06-24T00:00:00"}